IZI Medical Products, Inc.

The Company

IZI Medical Products, Inc. (IZI or the Company) is a leading provider of high-quality medical markers used in radiology, radiation therapy, and image-guided surgery procedures. IZI’s products range from fiducial markers used with MRI, CT, and PET technologies to highly engineered passive reflective markers used during complex image-guided surgery procedures. IZI is headquartered in Baltimore, Maryland.

The Situation

IZI retained KPMG Corporate Finance as its exclusive financial adviser. The shareholders were seeking liquidity at a valuation that reflected the Company’s profitability, strong industry position, and rapid growth, and a partner that understood the Company and the market opportunity, demonstrated a commitment to the industry, and had the resources to help significantly grow the business. In addition, the shareholders desired to remain with the business after the transaction and preferred a transaction that would reward them for continued value creation.

The Transaction

KPMG Corporate Finance ran a competitive, but controlled sale process. We identified both domestic and international strategic buyers and private equity firms that could meet the shareholders’ objectives of maximizing value and finding a partner that would be a strong cultural fit. Despite extremely difficult market conditions, KPMG Corporate Finance was successful in generating significant market interest, ultimately selling a majority equity stake in the business to Riverside Partners LLC. IZI’s CEO and CFO, Helen Zinreich Shafer and David Zinreich, remain with the Company in their existing roles, and in partnership with Riverside Partners, will continue to execute their growth strategy.